Press Releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 2, 2019- AMPREVENCE Study Met Primary and Secondary Endpoints - a 50% Relative Risk Reduction in Chlamydia Infection and a 78% Relative Risk Reduction in Gonorrhea Infection Compared to Placebo -
-
Nov 26, 2019- Submission Supported by Phase 3 AMPOWER Data -
-
Nov 14, 2019- San Diego Business Journal Recognizes the City's Top 15 Female Business Leaders -
-
Nov 6, 2019Company on Track for Amphora NDA Resubmission to the U.S. FDA